Although the 7 + 3 regimen has been the standard of care for acute myeloid leukemia for decades, it may be time to reassess its value and utility.
Marielle Fares, PharmDContributing Writer https://www.oncologynurseadvisor.com
Marielle Fares, PharmD, is a freelance medical writer and pharmacist based in Washington DC. She received her doctorate of Pharmacy (Pharm D) from the Lebanese American University and is a board-certified geriatric pharmacist. Before transitioning to full-time medical writing in 2017, Marielle worked as a pharmacist in chain drugstores and in private healthcare companies. Marielle has written on a wide range of specialties and disease states, including hematology-oncology, autoimmune diseases, cardiovascular, neuromuscular diseases, and pharmacotherapy.